Managing adverse events of multiple myeloma and anti-multiple myeloma treatment: A perspective on carfilzomib

Research output: Contribution to journal › Comment/debate

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{c7c2a93615154fc5986a8cc3f964ca2f,

title = "Managing adverse events of multiple myeloma and anti-multiple myeloma treatment: A perspective on carfilzomib",

author = "Siegel, \{David S.\}",

year = "2013",

month = dec,

day = "1",

language = "English",

volume = "27",

journal = "ONCOLOGY (United States)",

issn = "0890-9091",

publisher = "UBM Medica Healthcare Publications",

number = "SUPPL. 3",

}

TY - JOUR

T1 - Managing adverse events of multiple myeloma and anti-multiple myeloma treatment

T2 - A perspective on carfilzomib

AU - Siegel, David S.

PY - 2013/12/1

Y1 - 2013/12/1

UR - https://www.scopus.com/pages/publications/84893662159

M3 - Comment/debate

AN - SCOPUS:84893662159

SN - 0890-9091

VL - 27

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

IS - SUPPL. 3

ER -